MedTrace Logo

A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants

NCT07800897 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-09-02

No results posted yet for this study

Summary

The purpose of this study is to assess the food effect and drug interactions on drug levels of Navlimetostat in health adult female participants

Conditions

  • Healthy Female Adults

Interventions

DRUG

Navlimetostat

Specified dose on specified days

DRUG

Itraconazole

Specified dose on specified days

DRUG

Rifampin

Specified dose on specified days

DRUG

Midazolam

Specified dose on specified days

DRUG

Pantoprazole

Specified dose on specified days

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-26
Primary Completion
2027-03-25
Completion
2027-03-25
FDA Drug
Yes

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07800897 on ClinicalTrials.gov